Users Stopping Weight-Loss Medications Gain Back Pounds Far More Rapidly Than Those on Conventional Diets

A recent study suggests that individuals who stop using popular weight-loss injections like Wegovy and Mounjaro may regain reduced body mass far faster than those who stop traditional diet and exercise plans.

Research printed in a leading medical journal shows that while obese people can lose substantial amounts of their total mass while on the medication, the weight comes back at an average rate of nearly a kilo each month after stopping.

"Individuals purchasing such drugs need to be aware of the potential of quick rebound weight gain when the treatment ends," cautioned expert Dr. Susan Jebb.

Such speed of recovery implies a reversion to pre-treatment weight in about 18 months.

Weighing Therapies

The research, which examined dozens of studies involving thousands of patients, compared the results of GLP-1 agonists with older methods.

The team point out that people who shed pounds through dieting usually see a less rapid weight regain—perhaps 0.1 kg a month—after stopping.

Understanding the Fast Regain

Nutrition scientists suggest the mode of action of the injections explains the accelerated rebound.

GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which controls appetite.

"Long-term administration of the hormone levels several times higher than normal might result in the system to produce less of its endogenous hormone, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a dietetics expert.

"Discontinuation of this medication leads to appetite is no longer kept in check, making binge eating a significant risk."

A Lifelong Condition?

Health authorities recommend the injections for individuals with weight-linked health risks, alongside recommended lifestyle changes.

Professionals argue that, considering the likelihood of relapse, the therapy is often life-long.

This perspective is supported by drug manufacturers, who note that the findings "emphasize the chronic nature of obesity," comparing it to managing diseases like hypertension.

Patient Experiences

Individuals who have discontinued the jabs explain a powerful return of appetite.

"It felt as if a trigger flipping and you become starving," recalled a patient.

This difficulty is worsened if users have not established lasting lifestyle or habit changes during therapy.

Widespread Adoption

Survey data indicate that a significant number of people in the UK have used weight-loss jabs in the past year, with desire remaining high.

• Adoption is more common among women compared to males.
• The 40s and 50s age group shows the greatest usage rates.
• Many obtain the drugs through private healthcare rather than the NHS.

Ultimately, experts caution that while the jabs are potent agents for shedding pounds, they are not a standalone cure and lasting health benefits hinges on ongoing lifestyle changes.